ATE157544T1 - Verwendung von human-beta-interferon zur stimulierung der erythropoiesis - Google Patents

Verwendung von human-beta-interferon zur stimulierung der erythropoiesis

Info

Publication number: ATE157544T1
Authority: AT; Austria
Prior art keywords: human beta; beta interferon; stimulate erythropoiesis; erythropoiesis; stimulate
Prior art date: 1989-03-19

Application number

AT90104936T

Other languages

English (en)

Inventor

Rita Michalevicz

Original Assignee

Interpharm Lab Ltd

Univ Ramot

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-19

Filing date

1990-03-15

Publication date

1997-09-15

1990-03-15 Application filed by Interpharm Lab Ltd, Univ Ramot filed Critical Interpharm Lab Ltd

1997-09-15 Application granted granted Critical

1997-09-15 Publication of ATE157544T1 publication Critical patent/ATE157544T1/de

Links

101001033280 Homo sapiens Cytokine receptor common subunit beta Proteins 0.000 title 1
102000014150 Interferons Human genes 0.000 title 1
108010050904 Interferons Proteins 0.000 title 1
230000010437 erythropoiesis Effects 0.000 title 1
102000055647 human CSF2RB Human genes 0.000 title 1
229940079322 interferon Drugs 0.000 title 1
208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 abstract 2
208000010833 Chronic myeloid leukaemia Diseases 0.000 abstract 2
208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 abstract 2
101001054334 Homo sapiens Interferon beta Proteins 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Zoology (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

AT90104936T 1989-03-19 1990-03-15 Verwendung von human-beta-interferon zur stimulierung der erythropoiesis ATE157544T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IL89662A IL89662A (en)	1989-03-19	1989-03-19	Pharmaceutical compositions comprising interferon-beta

Publications (1)

Publication Number	Publication Date
ATE157544T1 true ATE157544T1 (de)	1997-09-15

Family

ID=11059803

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT90104936T ATE157544T1 (de)	1989-03-19	1990-03-15	Verwendung von human-beta-interferon zur stimulierung der erythropoiesis
AT94112221T ATE240116T1 (de)	1989-03-19	1990-03-15	Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT94112221T ATE240116T1 (de)	1989-03-19	1990-03-15	Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie

Country Status (12)

Country	Link
US (1)	US5104653A (de)
EP (2)	EP0388799B1 (de)
JP (1)	JP2883669B2 (de)
AT (2)	ATE157544T1 (de)
AU (1)	AU619960B2 (de)
CA (1)	CA2011992C (de)
DE (2)	DE69031355T2 (de)
DK (2)	DK0643973T3 (de)
ES (2)	ES2107414T3 (de)
GR (1)	GR3024763T3 (de)
IL (1)	IL89662A (de)
ZA (1)	ZA901994B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4128319A1 (de) *	1991-08-27	1993-03-04	Bioferon Biochem Substanz	Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
US5631219A (en) *	1994-03-08	1997-05-20	Somatogen, Inc.	Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en)	1994-03-08	2001-06-05	Somatogen, Inc.	Stabilized compositions containing hemoglobin
DE69636790T2 (de) *	1995-07-25	2007-10-11	Toray Industries, Inc.	Interferon-beta gegen knochenerkrankungen
EP1053004A2 (de)	1998-02-09	2000-11-22	University Of Southern California	Verwendung von angiotensin-analoga zur forderung der erythropoiesis
DE10020129C1 (de) *	2000-04-14	2001-11-15	Siemens Ag	Baugruppe mit Überspannungsableiter für eine Hochspannungsanlage
AU3070702A (en) *	2000-11-07	2002-05-21	Chiron Corp	Stabilized inteferon compositions
DE60108661T2 (de) *	2000-11-14	2006-01-05	Université Libre de Bruxelles	Herstellung und verwendung von dendritischen zellen
US7176278B2 (en)	2001-08-30	2007-02-13	Biorexis Technology, Inc.	Modified transferrin fusion proteins
US8084424B2 (en) *	2003-04-09	2011-12-27	University Of Utah Research Foundation	Compositions and methods related to erythropoietin
EP2327724A3 (de)	2004-02-02	2011-07-27	Ambrx, Inc.	Modifizierte humane Wachstumshormon-Polypeptide und deren Verwendungen
WO2005107384A2 (en) *	2004-03-31	2005-11-17	Nitromed, Inc.	Methods for treating blood disorders with nitric oxide donor compounds
AU2007217980A1 (en) *	2006-02-17	2007-08-30	Nitromed, Inc.	Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4460574A (en) *	1980-06-16	1984-07-17	Yabrov Alexander A	Prophylaxis or treatment of interferon-sensitive diseases
GB8412564D0 (en) *	1984-05-17	1984-06-20	Searle & Co	Structure and properties
CA1294215C (en) *	1986-10-27	1992-01-14	Ze'ev Shaked	Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US4851219A (en) *	1986-11-18	1989-07-25	Genentech, Inc.	Method for the treatment of chronic myelogenous leukemia
AU2855189A (en) *	1988-01-25	1989-07-27	Baker Cummins Dermatologicals, Inc.	Method of treating fibrotic disorders

1989
- 1989-03-19 IL IL89662A patent/IL89662A/xx active IP Right Grant
1990
- 1990-03-12 CA CA002011992A patent/CA2011992C/en not_active Expired - Lifetime
- 1990-03-15 DK DK94112221T patent/DK0643973T3/da active
- 1990-03-15 DE DE69031355T patent/DE69031355T2/de not_active Expired - Lifetime
- 1990-03-15 AT AT90104936T patent/ATE157544T1/de not_active IP Right Cessation
- 1990-03-15 EP EP90104936A patent/EP0388799B1/de not_active Expired - Lifetime
- 1990-03-15 DE DE69034076T patent/DE69034076T2/de not_active Expired - Lifetime
- 1990-03-15 ZA ZA901994A patent/ZA901994B/xx unknown
- 1990-03-15 DK DK90104936.1T patent/DK0388799T3/da active
- 1990-03-15 ES ES90104936T patent/ES2107414T3/es not_active Expired - Lifetime
- 1990-03-15 ES ES94112221T patent/ES2198409T3/es not_active Expired - Lifetime
- 1990-03-15 EP EP94112221A patent/EP0643973B1/de not_active Expired - Lifetime
- 1990-03-15 AT AT94112221T patent/ATE240116T1/de not_active IP Right Cessation
- 1990-03-16 US US07/495,027 patent/US5104653A/en not_active Expired - Lifetime
- 1990-03-16 AU AU51445/90A patent/AU619960B2/en not_active Expired
- 1990-03-19 JP JP2069519A patent/JP2883669B2/ja not_active Expired - Lifetime
1997
- 1997-09-17 GR GR970402418T patent/GR3024763T3/el unknown

Also Published As

Publication number	Publication date
GR3024763T3 (en)	1997-12-31
ES2107414T3 (es)	1997-12-01
ATE240116T1 (de)	2003-05-15
IL89662A0 (en)	1989-09-28
DE69031355D1 (de)	1997-10-09
JP2883669B2 (ja)	1999-04-19
EP0643973B1 (de)	2003-05-14
AU5144590A (en)	1990-09-20
ES2198409T3 (es)	2004-02-01
DE69034076T2 (de)	2003-11-20
EP0388799A3 (de)	1991-07-31
ZA901994B (en)	1990-12-28
AU619960B2 (en)	1992-02-06
CA2011992C (en)	2003-04-29
EP0643973A1 (de)	1995-03-22
IL89662A (en)	1997-11-20
US5104653A (en)	1992-04-14
EP0388799B1 (de)	1997-09-03
CA2011992A1 (en)	1990-09-19
DK0388799T3 (da)	1998-03-30
DK0643973T3 (da)	2003-09-08
EP0388799A2 (de)	1990-09-26
DE69031355T2 (de)	1998-01-08
JPH0314523A (ja)	1991-01-23
DE69034076D1 (de)	2003-06-18

Legal Events

Date	Code	Title	Description
1998-04-15	UEP	Publication of translation of european patent specification
2010-06-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE157544T1 (de)	1997-09-15	Verwendung von human-beta-interferon zur stimulierung der erythropoiesis
FI874706L (fi)	1988-04-28	Menetelmä glykosyloimattoman yhdistelmäinterferoni- :n stabiilien, farmaseuttisten koostumusten valmistamiseksi
SE8500460D0 (sv)	1985-02-01	Nya 6-substituerade furo-(3,4-c)-pyridin-derivat, sett for deras framstellning och terapeutiska kompositioner, innehallande foreningarna
DE69007744D1 (de)	1994-05-05	Verwendung von Interleukin 2 zur Behandlung von Leukämien.
DK49488D0 (da)	1988-02-01	Anaestesi-praeparat
NZ227944A (en)	1991-08-27	Synergistic pharmaceutical composition of a hybrid interferon and a muramylpeptide
DE69010294D1 (de)	1994-08-04	Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
ATE67783T1 (de)	1991-10-15	Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DK328088D0 (da)	1988-06-15	Farmaceutisk komposition til behandling af tumorer
FI863078A0 (fi)	1986-07-28	Kontinuerligt frigoerande peptidkompositioner.
IE871358L (en)	1987-11-27	Interferon for carcinoma
ATE130194T1 (de)	1995-12-15	Subkutane verabreichung des humanen choriongonadotropins.
IT1223485B (it)	1990-09-19	Procedimento per la preparazione di componenti ceramici
FI863079A0 (fi)	1986-07-28	Kontinuerligt frigoerande fenyletanolaminderivatkompositioner.
ATE74517T1 (de)	1992-04-15	Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
IT8714753V0 (it)	1987-12-24	Accorgimenti per la regolazione del rocher nelle tavole da windsurf